Taken together, our findings indicate that lncRNA NEAT1 might serve as a novel target for FHF therapy due to its regulation of H3K27me3 methylation-dependent promotion of LATS2. Here, LATS2 is linked to TNF receptor 1-associated periodic fever syndrome.